Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Skovronsky currently holds 137,481.11 shares of MYRIAD GENETICS INC (MYGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Skovronsky has been a net buyer of MYGN stock. They have purchased $2.0M and sold $0 worth of shares.
Daniel Skovronsky's most recent insider trade was on Nov 10, 2025, when they sold 179 shares at $0.00 per share.
Daniel Skovronsky serves as Executive at MYRIAD GENETICS INC (MYGN). They have executed 29 insider transactions totaling $2.0M over their tenure at the company.
Daniel Skovronsky holds the position of Executive at MYRIAD GENETICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Daniel Skovronsky has shown a buying trading pattern, with $2.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel Skovronsky was on Feb 12, 2024, when they purchased $9.5M worth of LLY shares. This transaction involved 12,910 shares at $737.26 per share.
Daniel Skovronsky currently owns 137,481.11 shares of MYRIAD GENETICS INC (MYGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Skovronsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Skovronsky has 29 Form 4 filings on record as an insider at MYRIAD GENETICS INC.
Set alerts for Daniel Skovronsky and 40,000+ other insiders.